Issue 43



Back Pain, Health Care

Chiropractors have become the third largest group of health professionals in the United States. The practice began in 1895, when Daniel David Palmer performed spinal manipulations, apparently restoring the sense of hearing in an individual. Chiropractors are licensed in all 50 states. Medicare covers chiropractic care for radiographically proven subluxation of the vertebral spine. Forty-five states have state-mandated benefits for chiropractic. There is an increasing number of insurance plans and managed care organizations offering chiropractic benefits. There is debate, both within the chiropractic profession and outside of it, whether chiropractic should be considered a nonsurgical musculoskeletal specialty or a broad-based alternative to medicine. Although chiropractic treatment frequently includes advice about exercise, nutritional supplements and lifestyle counseling, spinal manipulation is the treatment used most often, and is the one that is most closely identified with the practice of chiropractic in the United States. Chiropractic is a somewhat effective symptomatic therapy for some patients with acute low back pain and is no longer in dispute. What is in dispute is the effectiveness of spinal manipulation in relation to other therapies. In a recent study by Cherkin et al, N Engl J Med, 1998;339:1021-1029, results indicated that those who received chiropractic care and those who received McKenzie physical therapy incurred about $280 more in costs over the course of 2 years than patients who received an educational booklet. The author of this editorial suggests that chiropractic care for low back pain, at least in the United States, costs more than the usual supportive care delivered by health maintenance organizations. Whether the small symptomatic benefit and the enhanced satisfaction of patients is worth the cost is debatable. The chiropractic cost effectiveness may be improved by reducing the number of spinal manipulations, since the exact number needed to achieve maximal therapeutic benefit is not known. There is some evidence in randomized trials that spinal manipulation may be beneficial in patients with neck pain. Its cost effectiveness has not been established and there are still concerns about the safety of cervical manipulation. Physicians generally accept the role of chiropractic care in treating selected musculoskeletal problems but are opposed to its use for a variety of disorders such as hypertension, asthma and otitis media. A recent study by Balon et al on asthma and chiropractic manipulation (N Engl J Med 1998;339:1013-1020) showed no significant difference between groups in terms of physiologic outcome, symptoms, quality of life or patient's satisfaction. The author feels that chiropractic should not be considered a broad-based alternative to traditional medical care, but for some musculoskeletal conditions, chiropractic provides benefit to patients. The author suggests that the chiropractic profession needs to prove that there is a cost benefit to patients in health insurance companies with regard to their treatment approach to musculoskeletal conditions.

"What Role for Chiropractic in Health Care?," Shekelle PG, N Engl J Med, October 8, 1998;339(15):1074-1075.



Procedure Ordered at MWA by Emma McGowan, M.D. & Martin Gallagher, M.D.


What is Major Autohemotherapy (MAH)?

MAH is similar to an IV vitamin drip.  The difference is that your blood is first withdrawn from your vein into an IV bag, then medical ozone is infused into the bag.  After your blood and ozone are mixed together in the bag, the mixture will be dripped back into your vein.  As a result, no Ozone actually enters your bloodstream.  Rather the biological byproduct of the external mixing of your blood with ozone (ozinides, etc.) are actually creating the healing effect.

I read online that Ozone should not be injected into the blood stream?

That is correct.  Ozone injected directly into a vein or artery can cause a gas embolus that is dangerous to your health.  That is why MAH must be done under medical supervision and in the manner described above.  It is both safe and effective, properly applied in a medical setting by trained personnel.  See above.

What are the Indications for MAH?

  • Chronic Fatigue and CFS
  • Diabetic Circulatory Diseases
  • Fibromyalgia
  • Cancer (Complementary concept in oncology)
  • Chemical Sensitivities
  • Asthma and COPD
  • Chronic Allergies
  • Hepatitis B and C
  • LYME Disease
  • Herpes simplex and herpes zoster (shingles)
  • Osteo and Rheumatoid Arthritis
  • Eye diseases especially retinopathies
  • Auto Immune Diseases
  • Infections (viral, bacterial, fungal)
  • Heart and vascular disease
  • Low Immunity
  • Peripheral Artery Disease (PAD)
  • Acute hearing loss (vascular only)
  • Dementia and Cerebral Vascular Disease
  • Tinnitus (vascular only)
  • Post Stroke

As complementary therapy in general fatigue, geriatric and environmental medicine.

Who cannot receive MAH?

Those with a Glucose-6-phosphate dehydrogenase deficiency (favism, acute hemolytic anemia).  This is a rare condition pre-screened prior to treatment.

  • Hyperthyroidism if not controlled
  • The first 3 months of pregnancy
  • MAH is not indicated in leukemia

How often and how many treatments are required?

The frequency is usually 1-3 times per week.  The number of treatments can be up to 20 depending on the severity of the condition, age, and associated health problems.

Are there any side effects associated with the treatment? 

You may experience slight detox symptoms especially if you a have viral, bacterial or fungal component to your illness.  This is usually characterized by short term fatigue, hot and cold sensations, muscle or body aches (flu like symptoms).

What should I expect after a treatment?

MAH is an extremely beneficial medical therapy that has a long history of use in the US and especially Europe.  The reported benefits are increased energy, enhanced immune function, improved circulation, less pain, etc.



Excellent Doctor, Great Clinic, Wonderful Staff!
I have received treatment from Dr. Gallagher and his staff since the early 1990’s. I have always been satisfied with the results of my visits. He has treated me for many different problems through the years. I have always trusted his opinion concerning my health. I have taken my children and mother to him for diagnosis and treatments. I have always felt confident that he can help us. I have been blessed to have such a good doctor.

Vita Blackburn




Magnesium Therapy as Standard of Care

This is a review on the current research regarding IV magnesium and its benefit in myocardial infarction. The author notes that the Second Leicester Intravenous Magnesium Intervention Trial (Limit-2) was the largest and most powerful study of its kind supporting the growing body of evidence that IV magnesium sulfate is beneficial in the early treatment of acute myocardial infarction. The most significant outcome of the study was a 24% relative reduction in 28 day mortality for patients who received a 24 hour magnesium infusion, compared to a matched group of patients who did not. Some individuals, in their emergency medical realms, feel that magnesium should be the standard of care in myocardial infarction. It is noted that magnesium is significantly cheaper than other therapies including thrombolytics. Magnesium is inexpensive, almost without risk, and may have great benefit by its ability to reduce mortality 12 to 25%. Dr. Barnett, Professor and head of Pharmacology and Therapeutics at the University of Leicester, states that magnesium sulfate "is applicable to virtually all patients admitted to coronary care units, regardless of age." Dr. Slovis, Professor and Chairman of the Department of Emergency Medicine at Vanderbilt University Medical Center in Nashville, states that "physicians and patients should be asking not who received magnesium but who did not. Other than patients in volume depletion or renal failure, it is almost impossible to conclude that a patient having an acute MI shouldn't receive magnesium." There may be an increased incidence of bradycardia in magnesium-treated individuals. Dr. Slovis further states that no study has shown that magnesium is deleterious in large numbers of patients, and almost every study has shown that magnesium has benefitted by either increasing survival, decreasing ventricular arrhythmias, or both.

"Is IV Magnesium Now the Standard of Care in Acute Myocardial Infarction?", Patient Care, November 15, 1992;36-38.


Dr. Frank Shallenberger’s November Newsletter

When All Other Pain Treatments Fail, Try This....

If you have chronic pain of any kind, it might very well be caused by a common but completely ignored cause of pain. That’s true even if you are going to a pain specialist. Why? It’s because what I am going to tell you about is not taught in medical school or in pain specialty programs. But in many cases until it is addressed, there will be no hope for you other than pain pills and other treatments that decrease pain but don’t get rid of it. Listen to this remarkable story that Dr. Martin Gallagher, MD, DC reported at the last congress of The American Academy of Ozonotherapy.

The patient’s name is David. David developed a severe case of chest and abdominal pain. His doctors diagnosed it as a cyst in his bile duct. And so, they surgically removed the cyst and then re-routed the bile duct. The problem was that after the surgery, the pain persisted. According to David, the pain was aggravated by even minor movements. “I had to watch how I got out of a car and even tying my shoe laces.” After that he was sent to a pain clinic and prescribed various drugs, topical pain meds, and TENS (transcutaneous electrical nerve stimulation).  The treatments helped him cope, but did nothing to resolve the problem. So, after four years of continuous pain, David finally got smart and started looking for alternatives. That’s when he found Dr. Gallagher. 

Dr. Gallagher diagnosed the cause of the pain as being the result of two factors. One, the initial cause was an irritation of the nerves that underline the ribs called the intercostal nerves. This was brought on by one of his ribs being out of place. It’s the kind of thing that can happen with little to no trauma. It’s also the kind of thing that chiropractors specialize in. And since Dr. Gallagher is a chiropractor in addition to being a medical doctor, he knew all about this condition. The other cause was something called a scar neuroma. This is a condition in which scars can cause pain. In David’s case, the scar that was causing him so much pain was the scar from the surgery. No wonder the surgery didn’t alleviate the pain! Here’s what Dr. Gallagher did. 

Dr. Gallagher used chiropractic manipulation to correct the irritation in the intercostal nerves. He also injected the surgical scar with a combination of ozone and dextrose (pure sugar). These are commonly used treatments for scar neuromas. Here’s what happened.

 After two treatments, for the first time in five years, David noticed less pain. After six treatments, the pain had been decreased 50%. And after the 12th treatment, the pain was completely gone! Five years of pain gone in three months. And that’s not all. 

Dr. Gallagher went on to describe a case of chronic pain from shingles, a case of chronic neck pain after a surgical treatment for melanoma, and a case of trigeminal neuralgia. All of these patients had been suffering for years and had found very little help from the traditional-based doctors. And all of these cases were completely resolved using a combination of chiropractic, ozone therapy, and in one case acupuncture. So, here’s the point. 

If you have been suffering from chronic pain in any part of your body and have been told by your conventional doctors that there’s no treatment for it, don’t believe it.  At least not until you’ve seen a doctor like Dr. Gallagher, who knows how to combine alternative therapies with ozone therapy.

You can find Dr. Gallagher in Pittsburgh, PA. His phone number is 724-523-5505. You can find other doctors trained in these techniques at



The proposed mechanisms of action of echinacea extract include immunostimulation, inhibition of viral replication and antiinflammatory effects. In a placebo-controlled, randomized trial involving 302 volunteers comparing Echinacea angustifolia root extract, Echinacea purpurea root extract and placebo, results found no difference among the groups in time to occurrence of an upper respiratory infection or in the percentage of subjects in each group who developed upper respiratory infection. An 8-week trial in 109 patients comparing Echinacea purpurea herb extract with placebo found no effect on the incidence, duration or severity of upper respiratory infections. In another trial using a rhinovirus challenge in volunteers, there was no effect of echinacea extract on the incidence of experimentally induced infection. The use of combination products, which includes echinacea, for the treatment of upper respiratory infections has been reported to show some benefit, but there are multiple concerns about these trials from a scientific point of view. Adverse effects of echinacea include an unpleasant taste, allergic skin reactions and anaphylaxis, episodes of erythema nodosum, shivering, fever and muscle weakness with parenteral administration, but no significant differences in congenital malformations. The purity of echinacea products sold is unknown. In one study of 12 products marketed in the U.S., the percentage of phenolic compounds such as cichoric acid varied from brand to brand and within different lots of a single brand. The authors conclude that there is no convincing evidence that echinacea decreases severity or shortens the duration of upper respiratory infections.

"Echinacea for Prevention and Treatment of Upper Respiratory Infections," The Med Lett, April 1, 2002;44(1127):29-32.


Bio-Oxidative Therapies Offered at MWA:

  • 1